The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 329.00
Bid: 326.50
Ask: 328.50
Change: -5.00 (-1.50%)
Spread: 2.00 (0.613%)
Open: 326.00
High: 331.50
Low: 326.00
Prev. Close: 334.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Investec prefers 888 over Entain

Tue, 28th Sep 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

CITIGROUP RAISES BRITISH LAND TO 'NEUTRAL' ('SELL') - TARGET 526 (285) PENCE

----------

CITIGROUP RAISES LAND SECURITIES TO 'NEUTRAL' ('SELL') - TARGET 755 (506) PENCE

----------

UBS RAISES SPIRAX-SARCO PRICE TARGET TO 16,000 (12,500) PENCE - 'NEUTRAL'

----------

UBS RAISES DS SMITH PRICE TARGET TO 422 (414) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1,680 (1,650) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS SAGE GROUP TO 'SELL' ('NEUTRAL') - TARGET 700 (660) PENCE

----------

INVESTEC INITIATES ENTAIN WITH 'HOLD' - TARGET 2,400 PENCE

----------

JPMORGAN RAISES UNITED UTILITIES TARGET TO 1,060 (1,050) PENCE - 'OVERWEIGHT'

----------

HSBC RAISES FLUTTER TO 'BUY' (HOLD) - PRICE TARGET 17,400 (14,000) PENCE

----------

UBS CUTS MONDI PRICE TARGET TO 2,100 (2,200) PENCE - 'BUY'

----------

UBS CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 3,500 (3,600) PENCE - 'BUY'

----------

JPMORGAN RAISES ROLLS-ROYCE PRICE TARGET TO 150 (130) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

RBC RAISES ELECTROCOMPONENTS TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1,350 (1,070) PENCE

INVESTEC RESUMES 888 HOLDINGS WITH 'BUY' - TARGET 660 PENCE

JEFFERIES RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,450 (1,180) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES RYANAIR PRICE TARGET TO 17.5 (16.8) EUR - 'NEUTRAL'

----------

PEEL HUNT RAISES NEXT FIFTEEN TO 'ADD' ('HOLD') - TARGET 1,220 (1,130) PENCE

----------

PEEL HUNT RAISES GAMMA COMMUNICATIONS TO 'BUY' ('HOLD') - TARGET 2,225 PENCE

----------

BERENBERG RAISES SUPERDRY PRICE TARGET TO 280 (235) PENCE - 'HOLD'

----------

PEEL HUNT INITIATES CLIPPER LOGISTICS WITH 'HOLD' - TARGET 865 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2018 10:14

First patient successfully dosed with Oxford BioMedica's OXB-102

(Sharecast News) - Gene and cell therapy group Oxford BioMedica noted on Thursday that its partner, Axovant Sciences - a company developing innovative gene therapies for neurologic and neuromuscular diseases - has announced the successful dosing of the first patient in a clinical study of AXO-Lenti-PD, also known as OXB-102.

Read more
13 Sep 2018 15:46

'Transformative year' sees Oxford Biomedica profit from two huge contracts

(Sharecast News) - Biopharmaceutical company Oxford Biomedica saw its shares rise on Thursday after its first half gross income more than doubled due to two huge contracts.

Read more
22 May 2018 16:13

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 23 MayBovis Homes GroupSt James's Place Keller GroupGamma Emerging

Read more
4 May 2018 11:57

Oxford BioMedica To Cut Share Capital Through Consolidation (ALLISS)

LONDON (Alliance News) - Oxford BioMedica PLC said Friday it is proposing reducing the issued share capital of the company by a factor of 50 through a share capital consolidation.On Oxford

Read more
15 Mar 2018 11:45

Oxford Biomedica Loss Narrows, Revenue Grows In Transformational 2017

LONDON (Alliance News) - Gene therapy firm Oxford Biomedica PLC said Thursday its 2017 loss narrowed after revenue grew significantly on product progress and finance costs in

Read more
9 Mar 2018 17:16

Oxford BioMedica To Raise GBP21 Million Via Discounted Share Issue (ALLISS)

LONDON (Alliance News) - Oxford BioMedica PLC said Friday it intends to raise GBP20.5 million via a accelerated share book build process to fund the expansion a

Read more
10 Oct 2016 14:19

Oxford BioMedica's RetinoStat achieves 'favourable safety profile' in tests

(ShareCast News) - AIM-listed pharmaceutical Oxford BioMedica's RetinoStat, the first ocular lentiviral gene therapy to be administered in humans, demonstrated a "favourable safety profile with no serious adverse events" in its phase one study. Results of the study, which were previously published i

Read more
28 Jul 2016 09:05

Oxford BioMedica Gets Approval To Manufacture Drugs At New Facilities

Read more
7 Jun 2016 06:48

Oxford BioMedica Signs New Non-Exclusive Licence Deal With MolMed

Read more
2 Jun 2016 11:03

LONDON MARKET MIDDAY: Platinum Firm Gleams Ahead Of ECB, OPEC Outcomes

Read more
2 Jun 2016 09:16

Oxford Biomedica Signs Collaboration Deal With Green Cross LabCell

Read more
31 May 2016 15:04

UK Shareholder Meetings Calendar - Next 7 Days

Read more
24 May 2016 10:42

DIRECTOR DEALINGS: Oxford BioMedica Chairman Ups Interest

Read more
6 May 2016 09:28

WINNERS & LOSERS SUMMARY: Interserve Shares Demolished By Warning

Read more
6 May 2016 07:37

Oxford Biomedica Welcomes Positive LentiVector Test Data

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.